RBC Capital Sticks to Their Buy Rating for Healthpeak Properties (DOC)

RBC Capital analyst Michael Carroll maintained a Buy rating on Healthpeak Properties yesterday and set a price target of $21.00. The company’s shares closed yesterday at $19.55.

Claim 55% Off TipRanks

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Carroll covers the Real Estate sector, focusing on stocks such as Stag Industrial, Kilroy Realty, and Healthpeak Properties. According to TipRanks, Carroll has an average return of 7.9% and a 61.76% success rate on recommended stocks.

In addition to RBC Capital, Healthpeak Properties also received a Buy from Robert W. Baird’s Wes Golladay in a report issued yesterday. However, on the same day, UBS assigned a Hold rating to Healthpeak Properties (NYSE: DOC).

Based on Healthpeak Properties’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $752.95 million and a net profit of $193.63 million. In comparison, last year the company earned a revenue of $702.89 million and had a net profit of $42.83 million

Based on the recent corporate insider activity of 34 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of DOC in relation to earlier this year. Earlier this month, Scott R Bohn, the CDO and Head of Lab of DOC sold 10,989.00 shares for a total of $213,736.05.